CV Sciences Launches PlusHLTH.com, lengthening its Consumer Platform beyond Cannabinoids

On August 12, 2026, CV Sciences has launched a new website, PlusHLTH.com, thereby extending its consumer wellness platform to include products other than cannabinoids. The website is part of the company's +PlusHLTH brand, which offers science-supported, non-cannabinoid products aimed at promoting healthy aging, supporting active lifestyles, enhancing performance, improving nutrition, and addressing everyday wellness needs. The platform establishes a distinct identity from the company's existing CBD business, allowing customers to discover dietary supplements and plant-based nutrition products via a specific direct-to-consumer route.

The range of products on offer consists of supplements in both capsule and gummy form, as well as Empowr, a plant-based protein product that contains creatine. CV Sciences also intends to bring out further formulations and delivery methods as the brand develops. This move is a strategic effort to diversify its product range and could help decrease the company's dependence on the cannabinoid sector by opening up possibilities in the wider health and nutrition field. By combining its product range with educational material, PlusHLTH.com hopes to increase consumer engagement, assist customers in making informed purchases, and position CV Sciences as a more comprehensive wellness company.

Impact on the Nutraceuticals Industry

The global nutraceuticals market size was accounted at USD 626.19 billion in 2025 and predicted to increase from USD 672.29 billion in 2026 to approximately USD 1,102.94 billion by 2035, representing a CAGR of 5.82% from 2026 to 2035.

According to Precedence Research, the increasing stress on science-backed products and educational material could attract consumers who are looking for a more informed way of taking supplements. PlusHLTH's concentration on healthy aging, metabolism, cognitive health, cardiovascular wellness, vitality, and performance covers a number of fast-growing areas in the nutraceuticals infrastructure. The launch has the potential to accelerate competition in the dietary supplements and nutraceuticals sector by establishing CV Sciences as a wellness company.

The company's intention to introduce further formulations and delivery methods could also help it reach a wider market audience. The step shows how well-established supplement companies can diversify into related wellness areas while simultaneously building stronger direct relationships with consumers.  In response, competitors might choose to strengthen their scientific credentials, enhance consumer education, create more targeted product lines, and extend their nutritional capabilities.

Impact on the CBD Consumer Health Industry

The global CBD consumer health market size was calculated at USD 23.94 billion in 2025 and is predicted to reach around USD 84.94 billion by 2035, expanding at a CAGR of 14.01% from 2026 to 2035.

According to Precedence Research, in the cannabinoid and CBD wellness sector, PlusHLTH.com points out how important diversification is becoming. By separating its non-cannabinoid range from its existing CBD business, CV Sciences is enabling PlusHLTH to maintain its own market positions. This approach might help the company decrease its reliance on the cannabinoid area while at the same time still serving its current base of CBD customers.

It is possible that other cannabinoid companies will look at adopting similar strategies in order to expand their revenue opportunities and build more diversified consumer health portfolios. The step could indicate a wider trend among wellness companies to enter related areas such as nutrition, performance, healthy aging, and dietary supplementation. Since businesses in the cannabinoid market are having to deal with changing consumer preferences and increasing competition, expanding into complementary product lines could become ever more valuable.

Impact on the Wellness Technology Industry

PlusHLTH.com might strengthen competition in the digital-first wellness sector by using its proprietary platform to combine e-commerce, educational content, and consumer engagement. Instead of just acting as an online store, the platform is based on CV Sciences’ Health Intelligence approach, which links consumer health information with personalized product discovery.

This method enables the company to have greater control over the customer journey, brand communication, product education, and future product launches. It could also yield valuable consumer insights to support product development and marketing strategies. The launch might therefore prompt other supplement and wellness businesses to invest more heavily in wellness technology.

Expert Opinion

As per expert point of view, CV Sciences is expanding beyond cannabinoids is a strategically important step since it opens up new potential areas for growth while at the same time enabling its existing CBD business to keep its own place in the market. The wider wellness market is very competitive and is merely increasing the range of products. Because of its scientific background, the company has a potentially credible basis for entering the areas of nutritional supplements, healthy aging, and performance.

It will be necessary to have differentiated formulations, credible scientific evidence, effective consumer education and strong customer retention. These initiatives might yield useful consumer data and give the company better control over the purchasing process, though customer acquisition costs and competition in the marketplace are still significant problems. Only if CV Sciences can turn its expertise and brand credibility into attractive non-cannabinoid products will it drive expansion through diversification efforts and a real long-term growth platform.